 0 Table of Contents |
  1 Accueil |
  2 Analyse automatique |
  3 Téléchargements et usages |
  4 Méthode |
  5 Résultats |
  6 Discussion |
  7 Glossaire |
  8 Artifacts Summary |
   8.1 CareSite OMOP Table |
   8.2 Concept OMOP Table |
   8.3 Condition Era OMOP Table |
   8.4 Condition Occurrence OMOP Table |
   8.5 Cost OMOP Table |
   8.6 Death OMOP Table |
   8.7 Device Exposure OMOP Table |
   8.8 Dose Era OMOP Table |
   8.9 Drug Era OMOP Table |
   8.10 Drug Occurrence OMOP Table |
   8.11 Episode Event OMOP Table |
   8.12 Episode OMOP Table |
   8.13 Fact Relationship OMOP Table |
   8.14 Location OMOP Table |
   8.15 LogicalBundle |
   8.16 Measurement OMOP Table |
   8.17 Note NLP OMOP Table |
   8.18 Note OMOP Table |
   8.19 Observation OMOP Table |
   8.20 Observation Period OMOP Table |
   8.21 Payer Plan Period OMOP Table |
   8.22 Person OMOP Table |
   8.23 Procedure Occurrence OMOP Table |
   8.24 Provider OMOP Table |
   8.25 Specimen OMOP Table |
   8.26 Visit Detail OMOP Table |
   8.27 Visit Occurrence OMOP Table |
   8.28 Profil de Claim pour le champ MCO du PMSI |
   8.29 Profil de Claim pour le PMSI |
   8.30 Résultat de laboratoire |
   8.31 Activité physique |
   8.32 Blood Pressure |
   8.33 Body Height |
   8.34 Body Weight |
   8.35 Consommation d'alcool |
   8.36 Consommation d'autres drogues |
   8.37 Consommation de tabac |
   8.38 Fonction rénale |
   8.39 French branded name Medication |
   8.40 French compound Medication |
   8.41 French non proprietary name Medication |
   8.42 French Ucd Part Medication |
   8.43 Patient |
   8.44 Prescription de médicaments |
   8.45 Prise de médicaments |
   8.46 RSS du PMSI MCO |
   8.47 Temps de céphaline activée |
   8.48 Urémie |
   8.49 Address |
   8.50 Range with UCUM quantity units |
   8.51 Ratio with UCUM quantity units |
   8.52 SimpleQuantity with UCUM quantity unit |
   8.53 Actes CCAM pour le PMSI |
   8.54 Exercice Status Type |
   8.55 French Medicinal product Dose form |
   8.56 French Medicinal Product only |
   8.57 French Route of Administration |
   8.58 Liste des analyses biologiques socle des EDS |
   8.59 Liste des analyses correspondant à l'estimation du DFG - socle des EDS |
   8.60 Liste des diagnostiques CIM-10 acceptable en DA pour les PMSI MCO et HAD |
   8.61 Liste des diagnostiques CIM-10 acceptable en DP pour les PMSI MCO et HAD |
   8.62 Liste des diagnostiques CIM-10 acceptable en DR pour les PMSI MCO et HAD |
   8.63 Liste des diagnostiques CIM-10 pour le PMSI |
   8.64 Liste des status pour l'Observation de consommation de tabac |
   8.65 Liste des unités possibles pour une estimation du débit de filtration glomérulaire - socle des EDS |
   8.66 Smoking status comprehensive |
   8.67 Smoking Status Pack Years SCT |
   8.68 Smoking Status Type |
   8.69 Smoking Status Type from LOINC |
   8.70 ValueSet des type fr des claims |
   8.71 Categorie d'information pour les supporting information |
   8.72 CCAM |
   8.73 CIM 10 PMSI |
   8.74 mode PMSI |
   8.75 type de diagnostic du PMSI MCO |
   8.76 type PMSI |
   8.77 Mapping Patient resource to Death OMOP Domain |
   8.78 Mapping Patient resource to Location OMOP Domain |
   8.79 Mapping Observation laboratory resources to Measurement OMOP Domain |
   8.80 FHIR EDS Patient to Tables CDM OMOP |
   8.81 Mapping Patient resource to Person OMOP Domain |
   8.82 Mapping simple Observation laboratory resources to Measurement OMOP Domain |
   8.83 HL7 Gender to OHDSI Gender |
   8.84 LabAnalyses |
   8.85 LabComparator |
   8.86 LabUnit |
   8.87 alcohol-use-status-example-1 |
   8.88 assurance-maladie |
   8.89 blood-pressure-example-1 |
   8.90 body-height-example-1 |
   8.91 body-weight-example-1 |
   8.92 claim-example-1 |
   8.93 coverage-example-1 |
   8.94 exercise-status-example-1 |
   8.95 exercise-status-example-2 |
   8.96 laboratory-fonction-renale-example-1 |
   8.97 laboratory-tca-example-1 |
   8.98 laboratory-uremie-example-1 |
   8.99 organization-psl |
   8.100 patient-example-1 |
   8.101 practitioner-role-example-1 |
   8.102 smoke-use-status-example-1 |
   8.103 substance-use-status-example-1 |